AA
Apriem Advisors’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,605
| Closed | -$205K | – | 191 |
|
|
2025
Q1 | $205K | Hold |
1,605
| – | – | 0.02% | 176 |
|
|
2024
Q4 | $212K | Sell |
1,605
-20
| -1% | -$2.64K | 0.02% | 176 |
|
|
2024
Q3 | $237K | Sell |
1,625
-18
| -1% | -$2.62K | 0.03% | 159 |
|
|
2024
Q2 | $226K | Buy |
1,643
+8
| +0.5% | +$1.1K | 0.03% | 159 |
|
|
2024
Q1 | $224K | Sell |
1,635
-3,000
| -65% | -$412K | 0.03% | 159 |
|
|
2023
Q4 | $630K | Hold |
4,635
| – | – | 0.08% | 85 |
|
|
2023
Q3 | $567K | Sell |
4,635
-150
| -3% | -$18.3K | 0.08% | 87 |
|
|
2023
Q2 | $608K | Hold |
4,785
| – | – | 0.09% | 85 |
|
|
2023
Q1 | $618K | Sell |
4,785
-300
| -6% | -$38.7K | 0.1% | 79 |
|
|
2022
Q4 | $668K | Hold |
5,085
| – | – | 0.12% | 79 |
|
|
2022
Q3 | $595K | Hold |
5,085
| – | – | 0.11% | 84 |
|
|
2022
Q2 | $598K | Sell |
5,085
-300
| -6% | -$35.3K | 0.1% | 81 |
|
|
2022
Q1 | $702K | Hold |
5,385
| – | – | 0.1% | 78 |
|
|
2021
Q4 | $822K | Hold |
5,385
| – | – | 0.12% | 73 |
|
|
2021
Q3 | $871K | Hold |
5,385
| – | – | 0.12% | 68 |
|
|
2021
Q2 | $881K | Sell |
5,385
-666
| -11% | -$109K | 0.13% | 70 |
|
|
2021
Q1 | $911K | Buy |
6,051
+3,246
| +116% | +$489K | 0.14% | 68 |
|
|
2020
Q4 | $425K | Sell |
2,805
-2,500
| -47% | -$379K | 0.08% | 81 |
|
|
2020
Q3 | $718K | Sell |
5,305
-1,510
| -22% | -$204K | 0.13% | 63 |
|
|
2020
Q2 | $932K | Buy |
6,815
+1,050
| +18% | +$144K | 0.19% | 55 |
|
|
2020
Q1 | $621K | Sell |
5,765
-1,200
| -17% | -$129K | 0.15% | 62 |
|
|
2019
Q4 | $839K | Buy |
6,965
+950
| +16% | +$114K | 0.16% | 55 |
|
|
2019
Q3 | $598K | Buy |
6,015
+30
| +0.5% | +$2.98K | 0.13% | 68 |
|
|
2019
Q2 | $653K | Buy |
5,985
+50
| +0.8% | +$5.46K | 0.2% | 69 |
|
|
2019
Q1 | $664K | Sell |
5,935
-45
| -0.8% | -$5.04K | 0.18% | 64 |
|
|
2018
Q4 | $577K | Buy |
5,980
+85
| +1% | +$8.2K | 0.2% | 68 |
|
|
2018
Q3 | $719K | Sell |
5,895
-210
| -3% | -$25.6K | 0.16% | 67 |
|
|
2018
Q2 | $670K | Buy |
6,105
+2,550
| +72% | +$280K | 0.15% | 64 |
|
|
2018
Q1 | $379K | Sell |
3,555
-540
| -13% | -$57.6K | 0.09% | 83 |
|
|
2017
Q4 | $437K | Buy |
4,095
+2,735
| +201% | +$292K | 0.11% | 74 |
|
|
2017
Q3 | $454K | Buy |
1,360
+220
| +19% | +$73.4K | 0.11% | 79 |
|
|
2017
Q2 | $353K | Buy |
1,140
+30
| +3% | +$9.29K | 0.09% | 86 |
|
|
2017
Q1 | $326K | Buy |
1,110
+200
| +22% | +$58.7K | 0.09% | 89 |
|
|
2016
Q4 | $241K | Buy |
910
+545
| +149% | +$144K | 0.07% | 108 |
|
|
2016
Q3 | $106K | Sell |
365
-215
| -37% | -$62.4K | 0.03% | 160 |
|
|
2016
Q2 | $149K | Buy |
+580
| New | +$149K | 0.05% | 132 |
|
|
2014
Q2 | – | Sell |
-210
| Closed | -$50K | – | 488 |
|
|
2014
Q1 | $50K | Buy |
210
+160
| +320% | +$38.1K | 0.02% | 214 |
|
|
2013
Q4 | $11K | Buy |
+50
| New | +$11K | ﹤0.01% | 347 |
|